Keloid Management: A Retrospective Case Review on a New Approach Using Surgical Excision, Platelet-Rich Plasma, and In-office Superficial Photon X-ray Radiation Therapy
Michael E. Jones; Cherrell Hardy, BSN, RN; and Julie Ridgway, BSN, RN Jones Keloids Paper – July 2016 Advances in Skin & Wound Care
Provide Your Patients with an Alternative to Mohs Surgery: The SRT-100™
As a form of treatment for basal cell carcinoma and squamous cell carcinoma, Mohs surgery has lead the forefront of surgery options for decades. You may prefer Mohs surgery rather than other forms of surgery because of its precision due to its microscopic nature. However, there are no procedures without their drawbacks. You can’t put […]
Looking for an Alternative to Mohs Surgery? Look No Further than the SRT-100™
Each year millions of Americans are diagnosed with some form of squamous cell carcinoma or basal cell carcinoma. Naturally, this forces those affected to seek out forms of treatment to get rid of the cancerous cells, which are located on the outer layer of the skin. One of those types of treatments is Mohs surgery. […]
Sensus Healthcare Rings the Opening Bell at the Nasdaq MarketSite
Sensus Healthcare participated in an opening bell ringing ceremony at the Nasdaq MarketSite on Thursday, June 9, 2016. With important employees, partners and families on hand, Sensus Healthcare’s Chief Executive Officer, Joseph Sardano, officially opened the trading day on Nasdaq. This ceremony comes on the heels of the successful Initial Public Offering (IPO) of Sensus […]
Sensus Healthcare, Inc. Announces Completion of Initial Public Offering, including Underwriters’ Exercise of Over-Allotment Option in Full
BOCA RATON, Fla., June 8, 2016 — Sensus Healthcare, Inc. (NASDAQ: SRTSU), a medical device company specializing in the treatment of non-melanoma skin cancers and other skin conditions, such as keloids, with superficial radiation therapy, today announced the completion of its initial public offering of 2,300,000 units at a public offering price of $5.50 per […]
ASDS: Skin Cancer Treatments Among Most Frequently Performed Procedures in 2015
Dermatologic surgeons performed nearly 10 million medical and cosmetic procedures in 2015 – up five percent since 2014 and 27 percent since 2012, according to the 2015 American Society for Dermatologic Surgery (ASDS) Survey on Dermatologic Procedures. For the fourth year in a row, skin cancer treatments ranked as the most-performed procedure (3.17 million) by ASDS members. […]
